How does aspirin relieve headaches, compared with newer headache drugs?
Aspirin is an older painkiller that reduces headache pain mainly by lowering prostaglandins. These signaling chemicals build up during pain and inflammation and can sensitize pain pathways. By blocking cyclooxygenase (COX) enzymes, aspirin reduces prostaglandin production, which helps blunt pain signaling. [1]
Newer headache medicines include drugs that target different steps in headache biology than COX/prostaglandins, such as:
- blocking the CGRP pathway (to reduce neuropeptide-driven headache signaling)
- blocking serotonin (5-HT) receptors involved in migraine pathways
- reducing trigeminal pain transmission through different receptor mechanisms than COX inhibition
Because their targets sit upstream or downstream of prostaglandins, they can work even when prostaglandin reduction alone is not enough, and they can be more specific to migraine mechanisms. [2][3]
What is aspirin’s mechanism for headache specifically (and what it does not target)?
Aspirin’s headache effect is largely indirect: it reduces inflammatory mediators (prostaglandins) that contribute to pain and peripheral sensitization. [1] That means its mechanism is not designed around the migraine-specific signaling systems that many modern drugs target (like CGRP or certain serotonin receptor circuits). [2][3]
How do CGRP-targeting drugs differ from aspirin?
CGRP (calcitonin gene-related peptide) drugs are designed to interfere with a signaling system that plays a key role in migraine pain transmission. Aspirin lowers prostaglandins via COX inhibition, while CGRP drugs target CGRP activity directly or block its receptor. That difference in target location helps explain why CGRP drugs are considered migraine-specific compared with general anti-inflammatory analgesics. [2]
How do triptans (serotonin-targeting) differ from aspirin?
Triptans work by activating serotonin (5-HT) receptors involved in migraine pathways, which can reduce trigeminal neuron activity and vascular pain signaling. Aspirin’s COX/prostaglandin mechanism is broader pain/inflammation suppression rather than this migraine-specific serotonin receptor activation. [3]
Why might people notice aspirin works differently than newer “migraine” drugs?
Because the mechanisms differ, response patterns can differ. Aspirin tends to help more with pain generated by prostaglandin-driven processes, while newer migraine drugs target pathways more tightly linked to migraine signaling (CGRP or serotonin receptor circuits). That can affect how quickly a patient feels relief and how well a medicine prevents attacks versus treating breakthrough pain. [1][2][3]
What about “aspirin-like” newer drugs—are they always different?
Not all newer headache drugs are mechanistically far from aspirin. Some newer options still act as NSAIDs or share COX/prostaglandin-related effects, but many of the most discussed “new” migraine-specific drugs target CGRP or serotonin receptors instead. The key distinction is whether a drug reduces prostaglandins via COX (aspirin-like) or targets migraine pathways like CGRP/5-HT (migraine-specific). [1][2][3]
Sources
[1] https://en.wikipedia.org/wiki/Aspirin
[2] https://en.wikipedia.org/wiki/Calcitoningene-relatedpeptide
[3] https://en.wikipedia.org/wiki/Triptan